Effect of METTL14 Silencing on Proliferation, Apoptosis, and eEF2 Expression in Hepatocellular Carcinoma Cells

Naglaa Ahmed Abdel-Wahed H. Shehata Magda I. Mohamad G. Hammouda A. A. ElGwad

Aug 2026 · Journal of Evolutionary Biochemistry and Physiology · Vol 62, pp. 1383 - 1393 · 0 citations · 37 references

TL;DR

It is indicated that METTL14 exerts a neoplastic nature, enhancing cell survival and reducing gene expression of eEF2, which could inform novel therapeutic strategies targeting the epitranscriptomic machinery in hepatocellular carcinoma (HCC).

DOI Semantic Scholar

View source

Similar papers

Oct 2026

METTL3-mediated m6A modification of PARP2 accelerates hepatocellular carcinoma progression.

Results showed that PARP2 was highly expressed in hepatocellular carcinoma and related to its poor prognosis, and METTL3-mediated PARP2 m6A modification plays a vital tumor-promoter role in hepatocellular carcinoma progression.

Meng-Ke Li, Yan Zhao, Yuan Li · Toxicology and Applied Pharm... · 0 citations

Open access Aug 2026

KIAA1429 knockdown alleviates osteosarcoma progression by destabilizing SLC7A11 mRNA via m6A methylation to promote ferroptosis

KIAA1429 knockdown may suppress OS progression by inhibiting m6A-dependent SLC7A11 expression, thereby promoting ferroptosis and targeting the KIAA1429/SLC7A11 axis may represent a promising therapeutic strategy for OS.

Hui Zeng, Yun-Yan Zhong, Ding-Biao Zeng et al. · International Journal of Onc... · 0 citations

Open access Sep 2026

Effect of EZH2 regulation of the JAK2/STAT3 signaling pathway on proliferation and apoptosis in non-small cell lung cancer cells

It is demonstrated that EZH2 promotes NSCLC progression through activation of the JAK2/STAT3 signaling pathway, identifying the EZH2-JAK2/STAT3 axis as a potential therapeutic vulnerability in this malignancy.

Shuang Wu, Wei Zhang · Oncology Report · 0 citations

Sep 2026

METTL1/USP48 Axis Stabilizes LCN2 Expression to Promote the Malignant Phenotypes of Cutaneous Squamous Cell Carcinoma

Clinically, these findings identify the METTL1/USP48/LCN2 pathway as a potential therapeutic target for cSCC and elucidated a novel oncogenic axis in cSCC, wherein METTL1 stabilized USP48 mRNA through m7G methylation modification, and USP48 in turn deubiquitinated and stabilized LCN2 protein.

Xiu-Qi Li, Lin Shu, Xiao-Qiang Li et al. · Applied Biochemistry and Bio... · 0 citations

2026

[Anwulignan inhibits malignant phenotypes of gastric cancer cells by antagonizing activation of the JAK1/STAT3 signaling pathway].

ANW inhibits malignant phenotype of gastric cancer cells by inhibiting the activation of the JAK1/STAT3 signaling pathway, thereby inducing cell cycle arrest, promoting apoptosis, and suppressing EMT and MMP-mediated invasion and migration, suggesting the potential of ANW as a therapeutic agent for gastric cancer.

Xin-Yue Liu, Ke-Ni Zhang, Tong Qiao et al. · Nan fang yi ke da xue xue ba... · 0 citations

Open access Sep 2026

Sophocarpine Inhibits Proliferation and Triggers Apoptosis in Breast Cancer Cells by Modulating the miR-21/PTEN/AKT and ERK1/2 Signaling Networks

Findings identify SC as a potential structural scaffold exhibiting preliminary anti-tumor activity against breast cancer cells, at least in part, through modulating miR-21 and inhibition of the AKT/mTOR/ERK1/2 survival network.

Y. R. Shahin, N. Elguindy, D. Ghareeb et al. · Pharmaceuticals · 0 citations